Skip to main content
Clinical Trials/CTRI/2024/05/068217
CTRI/2024/05/068217
Not yet recruiting
Phase 3 4

“A comparative study of Ultrasound guided Supraclavicular brachial plexus block using Bupivacaine alone and the combination of Bupivacaine and Buprenorphine in patients undergoing elective upper limb orthopaedic surgeries. ”

Zohra Fatima1 site in 1 country50 target enrollmentStarted: June 1, 2024Last updated:

Overview

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Zohra Fatima
Enrollment
50
Locations
1
Primary Endpoint
Onset of action is faster and duration of action is prolonged when Combination of Bupivacaine and Buprenorphine is used compared to Bupivacaine alone

Overview

Brief Summary

For ultrasound guided supraclavicular brachial plexus block, one group

received bupivacaine alone anad other group received bupivacaine and

buprenorphine. On comparing the two groups, it was found out that,

Onset of sensory blockade was similar in both the groups.

Onset of motor blockade was found to be earlier in bupivacaine alone

group.

Duration of analgesia was significantly prolonged in group that

received buprenorphine compared to bupivacaine alone.

The need for rescue analgesic is significantly delayed in the group that

received buprenorphine compared to bupivacaine alone.

There was no significant difference in the hemodynamic parameters in

both the groups.

There was no opioid related side effects in both the groups.

No other complications were seen in both the groups.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Assessed patients of ASA I and II status.
  • Both gender.
  • Normal biochemical and hematological parameters.
  • Age group between 20 -60years
  • Patients weighing 50-70 Kgs.
  • Mallampati score of I and II
  • No known neurological deficit
  • No local sepsis.

Exclusion Criteria

  • Patients who have not given consent.
  • Patients with anticipated difficult airway.
  • Neurological disorders
  • History of cardiovascular and respiratory disorders
  • Local bony deformities
  • History of bleeding disorders
  • Extremely obese patients.

Outcomes

Primary Outcomes

Onset of action is faster and duration of action is prolonged when Combination of Bupivacaine and Buprenorphine is used compared to Bupivacaine alone

Time Frame: 6 to 7 hours

Secondary Outcomes

  • Post operative analgesia is prolonged when combination of Bupivacaine and Buprenorphine are used(2to 3 hours)

Investigators

Sponsor
Zohra Fatima
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

ZOHRA FATIMA

Gulbarga institute of medical sciences

Study Sites (1)

Loading locations...

Similar Trials